Tags : Mobidiag


PharmaShots’ Key Highlights of Second Quarter 2021

The second quarter of 2021 witnesses major acquisitions, approvals, and clinical data. There are major alliances in this quarter which include Merck signed ~$1.2B supply agreement with US Government for Molnupiravir to treat COVID-19 The big acquisition took place during the quarter including Microsoft acquired Nuance for ~$19.7B, MorphoSys acquired Constellation for ~$1.7B Our team […]Read More

M&A MedTech

Hologic to Acquire Mobidiag for ~ $795M

Shots: Hologic to acquire Mobidiag for ~$795M which includes ~$714M in cash for Mobidiag’s equity and debt of $81M. The acquisition is expected to close in Q4’21 The acquisition will accelerate Hologic’s global footprints by enabling it to expand into the large, fast-growing acute care adjacency with a near-patient testing solution that offers ease of […]Read More